Vol. 62 – No. 1/2016
Bronchodilators or combination of long acting beta 2 adrenergic and inhaled steroids: another competition in the future?!
If we are looking into the real problems of chronic obstructive pulmonary disease (COPD) we can find out many current problems unsolved at this moment: it’s a prevalent major medical problem, underdiagnosed, unrecognized, untreated. The current therapies also have their own problems. Monotherapy with bronchodilators is sometimes not sufficient, combinations of different classes of bronchodilators sometimes have not well defined indications and the combination of bronchodilators and inhaled corticosteroids (ICS) is more criticized every day. If we are thinking also that the opinion leaders are speaking more and more about personalized treatment, the puzzle of diagnosis and therapy of COPD is becoming more difficult.
“Marius Nasta” Institute of Pulmonology Bucharest
26 ianuarie 2016